E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 3/14/2013 in the Prospect News PIPE Daily.

Tribute Pharmaceuticals completes $275,000 private placement of units

Units of one common share, two half-share warrants sold at $0.40 each

By Devika Patel

Knoxville, Tenn., March 14 - Tribute Pharmaceuticals Canada Inc. settled a $275,000 private placement of units on March 11, according to an 8-K filed Thursday with the Securities and Exchange Commission.

The company sold 687,500 units of one common share and two half-share warrants at $0.40 per unit.

One of the warrants will be exercisable at $0.50 for two years, with the other exercisable at $0.60 for five years. The strike prices are 35.14% and 62.16% premiums to the March 8 closing share price of $0.37.

Proceeds will be used for promotion of products, debt repayment, working capital and pending business development initiatives.

The pharmaceutical company is based in Milton, Ont.

Issuer:Tribute Pharmaceuticals Canada Inc.
Issue:Units of one common share and two half-share warrants
Amount:$275,000
Units:687,500
Price:$0.40
Warrants:Two half-share warrants per unit
Warrant expiration:Two years, five years
Warrant strike price:$0.50, $0.60
Settlement date:March 11
Stock symbol:OTCBB: TBUFF
Stock price:$0.37 at close March 8
Market capitalization:$16.24 million

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.